Portfolio company
Edesa Biotech
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops monoclonal antibody treatments for patients suffering from acute and chronic inflammatory and immune-related diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Granite Bio
This clinical-stage biotechnology company develops therapeutic antibodies to treat patients with inflammatory, autoimmune and fibrotic diseases.
Bionyra
This biopharmaceutical company develops monoclonal and bispecific antibodies for patients with severe immune-mediated inflammatory diseases, specifically inflammatory bowel disease and atopic dermatitis.
Aiolos Bio
This biopharmaceutical company develops monoclonal antibody therapies for patients suffering from respiratory and inflammatory conditions such as moderate-to-severe asthma.
Evommune
This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.
Innate Pharma
This biotechnology company develops antibody-based immunotherapies for cancer and inflammatory diseases for patients with unmet medical needs.
Bluefin Biomedicine
This biotechnology company develops first-in-class antibody medicines for patients with serious inflammatory and oncologic diseases.
Selecta Biosciences
This biopharmaceutical company develops nanoparticle immunomodulatory drugs to treat and prevent human diseases for patients with autoimmune disorders and rare genetic conditions.
Odyssey Therapeutics
This biopharmaceutical company develops oral small molecule and protein medicines for patients with autoimmune and inflammatory diseases.
